SCHEMBL14910069

SCHEMBL14910069

CC(C)(C)N(Cc1ccc(-c2cncc(Br)c2)cc1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
POLB P06746 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
PKM P14618 1/20 0.36
CYP2A6 P11509 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HDAC1 Q13547 1/20 0.36
ALOX15 P16050 1/20 0.35
XDH P47989 1/20 0.35
SLC22A12 Q96S37 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14909657 0.78 HTT (0.40) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL1684422 0.78 MEN1 (0.55) MEN1KMT2ALMNAALDH1A1HTT
SCHEMBL4159355 0.77 HRH3 (0.57) ALDH1A1HTTSMN1; SMN2MAPTCYP11B1
SCHEMBL27828797 0.73 LSS (0.39) KMT2AHTTSMN1; SMN2MAPTL3MBTL1
SCHEMBL3671038 0.73 CYP11B1 (0.40) MEN1KMT2ALMNAHTTSMN1; SMN2
SCHEMBL4164539 0.73 HDAC1 (0.37) KMT2AHTTSMN1; SMN2MAPTL3MBTL1
SCHEMBL27828812 0.73 HDAC1 (0.35) KMT2AHTTSMN1; SMN2MAPTL3MBTL1
SCHEMBL485977 0.72 SMN1; SMN2 (0.57) LMNAALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL23116262 0.72 MEN1 (0.51) MEN1KMT2ALMNAALDH1A1HTT
SCHEMBL17371937 0.72 MEN1 (0.50) MEN1KMT2ALMNAALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2589592-B1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM CORP (JP) 2018-08-22 EP disclosed
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-8772320-B2 2014-07-08 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed
EP-2589592-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF FUJIFILM Corporation (JP) 2013-05-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK MEN1 2870/4885KMT2A 1162/4885LMNA 3649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.